Structure-activity relationships in platelet-activating factor (PAF). 7. Tetrahydrofuran derivatives as dual PAF antagonists and acetylcholinesterase inhibitors. Synthesis and PAF-antagonistic activity-Reference-Cited by-同舟云学术

Structure-activity relationships in platelet-activating factor (PAF). 7. Tetrahydrofuran derivatives as dual PAF antagonists and acetylcholinesterase inhibitors. Synthesis and PAF-antagonistic activity

Published:1996-05 Issue:3 Volume:13 Page:189-205
ISSN:0929-7855
Container-title:Journal of Lipid Mediators and Cell Signalling
language:en
Short-container-title:Journal of Lipid Mediators and Cell Signalling

Author:

Texier Laurence Le,Favre Edith,Redeuilh Catherine,Blavet Nadine,Bellahsene Tounès,Dive Georges,Pirotzky Edouardo,Godfroid Jean-Jacques

Publisher

Elsevier BV

Subject

Pharmacology,Immunology

Reference31 articles.

1. Ab initio methods in quantum chemistry;Lawley,1985

2. Advances in Alzheimer therapy: cholinesterase inhibitors;Ashford;Neurobiol. Aging,1989

3. A highly stereoselective synthesis of davanone;Bartlett;Tetrahedron Lett.,1983

4. New hypothesis on the conformation of the PAF-receptor from the studies on the geometry of selected platelet-activating factor-antagonists;Batt;J. Lipid Mediators,1991

5. Platelet-activating factor is a synapse messenger and an intracellular modulator of gene expression;Bazan;J. Lipid Mediators.,1994

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypoxia‐inducible factor and bacterial infections in chronic obstructive pulmonary disease;Respirology;2019-10-30

2. Does upregulated host cell receptor expression provide a link between bacterial adhesion and chronic respiratory disease?;Journal of Translational Medicine;2016-10-26

3. Nanoparticles and microparticles for skin drug delivery;Advanced Drug Delivery Reviews;2011-05

4. PMS777, a New Cholinesterase Inhibitor with Anti-Platelet Activated Factor Activity, Regulates Amyloid Precursor Protein Processing In Vitro;Neurochemical Research;2008-08-29

5. A new acetylcholinesterase inhibitor with anti-PAF activity modulates oxidative stress and pro-inflammatory mediators release in stimulated RAW 264.7 macrophage cells. Comparison with tacrine;International Immunopharmacology;2007-12